These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12011455)

  • 1. Initiating oncogenic event determines gene-expression patterns of human breast cancer models.
    Desai KV; Xiao N; Wang W; Gangi L; Greene J; Powell JI; Dickson R; Furth P; Hunter K; Kucherlapati R; Simon R; Liu ET; Green JE
    Proc Natl Acad Sci U S A; 2002 May; 99(10):6967-72. PubMed ID: 12011455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.
    Deeb KK; Michalowska AM; Yoon CY; Krummey SM; Hoenerhoff MJ; Kavanaugh C; Li MC; Demayo FJ; Linnoila I; Deng CX; Lee EY; Medina D; Shih JH; Green JE
    Cancer Res; 2007 Sep; 67(17):8065-80. PubMed ID: 17804718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-tyrosine phosphatase epsilon. An isoform specifically expressed in mouse mammary tumors initiated by v-Ha-ras OR neu.
    Elson A; Leder P
    J Biol Chem; 1995 Nov; 270(44):26116-22. PubMed ID: 7592814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
    Amundadottir LT; Leder P
    Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.
    Morrison BW; Leder P
    Oncogene; 1994 Dec; 9(12):3417-26. PubMed ID: 7970700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer.
    Andrechek ER; Muller WJ
    Breast Cancer Res; 2000; 2(3):211-6. PubMed ID: 11250712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of intracisternal A-particle retrotransposons in primary tumors of oncogene-expressing transgenic mice.
    Dupressoir A; Heidmann T
    Oncogene; 1997 Jun; 14(24):2951-8. PubMed ID: 9205102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers.
    Andrechek ER; Laing MA; Girgis-Gabardo AA; Siegel PM; Cardiff RD; Muller WJ
    Cancer Res; 2003 Aug; 63(16):4920-6. PubMed ID: 12941816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice.
    Sevenich L; Werner F; Gajda M; Schurigt U; Sieber C; Müller S; Follo M; Peters C; Reinheckel T
    Oncogene; 2011 Jan; 30(1):54-64. PubMed ID: 20818432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.
    Landis MD; Seachrist DD; Montañez-Wiscovich ME; Danielpour D; Keri RA
    Oncogene; 2005 Aug; 24(33):5173-90. PubMed ID: 15897883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference of mouse polyomavirus with the c-myc gene and its product in mouse mammary adenocarcinomas.
    Holländerová D; Raslová H; Blangy D; Forstová J; Berebbi M
    Int J Oncol; 2003 Aug; 23(2):333-41. PubMed ID: 12851682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.
    Jacquemart IC; Springs AE; Chen WY
    Int J Oncol; 2009 Feb; 34(2):517-28. PubMed ID: 19148488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammary epithelial cell transformation: insights from cell culture and mouse models.
    Dimri G; Band H; Band V
    Breast Cancer Res; 2005; 7(4):171-9. PubMed ID: 15987472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of NF-kappaB activity and NF-kappaB p65 subunit expression by ras and polyoma middle T oncogenes in human colonic Caco-2 cells.
    Cadoret A; Bertrand F; Baron-Delage S; Lévy P; Courtois G; Gespach C; Capeau J; Cherqui G
    Oncogene; 1997 Apr; 14(13):1589-600. PubMed ID: 9129150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific protection against breast cancers by cyclin D1 ablation.
    Yu Q; Geng Y; Sicinski P
    Nature; 2001 Jun; 411(6841):1017-21. PubMed ID: 11429595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
    Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
    Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene.
    Sepulveda AR; Finegold MJ; Smith B; Slagle BL; DeMayo JL; Shen RF; Woo SL; Butel JS
    Cancer Res; 1989 Nov; 49(21):6108-17. PubMed ID: 2551499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mouse model with T58A mutations in Myc reduces the dependence on KRas mutations and has similarities to claudin-low human breast cancer.
    Hollern DP; Yuwanita I; Andrechek ER
    Oncogene; 2013 Mar; 32(10):1296-304. PubMed ID: 22525269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.